New York City-based Dermatologist Dendy Engelman, MD, FACMS, FAAD, is the newest member of AV Laboratories’ Scientific Advisory Board.
In her role on the AV Laboratories Scientific Advisory Board, Dr. Engelman will provide expert guidance on clinical strategy, product development, and scientific positioning.
The skincare company’s core technology is AVL SOM3.
“Dr. Engelman represents the intersection of clinical excellence and future-forward dermatology,” says Sylwia Pawlaczyk, the AV Laboratories Chief Operating Officer, in a news release. “Her expertise and perspective will be invaluable as we continue to elevate the standard for science-backed skincare and invest in technologies that support skin wellness at the molecular level.”
Dr. Engelman adds, “I’m excited to join the Scientific Advisory Board at AV Laboratories at a time when the conversation around longevity and skin health is rapidly evolving. AVL’s commitment to rigorous science and meaningful innovation aligns deeply with my own philosophy of patient-first, evidence-based care. I look forward to contributing to the brand’s continued research and development efforts.”